Ma, H.;                     Bao, Y.;                     Niu, S.;                     Wang, S.;                     Li, Y.;                     He, H.;                     Zhang, N.;                     Fang, W.    
        Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy. Pharmaceuticals 2023, 16, 758.
    https://doi.org/10.3390/ph16050758
    AMA Style
    
                                Ma H,                                 Bao Y,                                 Niu S,                                 Wang S,                                 Li Y,                                 He H,                                 Zhang N,                                 Fang W.        
                Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy. Pharmaceuticals. 2023; 16(5):758.
        https://doi.org/10.3390/ph16050758
    
    Chicago/Turabian Style
    
                                Ma, Hao,                                 Yunyang Bao,                                 Shuaishuai Niu,                                 Shaorong Wang,                                 Yiming Li,                                 Hongwei He,                                 Na Zhang,                                 and Weishuo Fang.        
                2023. "Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy" Pharmaceuticals 16, no. 5: 758.
        https://doi.org/10.3390/ph16050758
    
    APA Style
    
                                Ma, H.,                                 Bao, Y.,                                 Niu, S.,                                 Wang, S.,                                 Li, Y.,                                 He, H.,                                 Zhang, N.,                                 & Fang, W.        
        
        (2023). Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy. Pharmaceuticals, 16(5), 758.
        https://doi.org/10.3390/ph16050758